Leontien Bosch

859 total citations
18 papers, 637 citations indexed

About

Leontien Bosch is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Leontien Bosch has authored 18 papers receiving a total of 637 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in Leontien Bosch's work include Chemokine receptors and signaling (8 papers), Cervical Cancer and HPV Research (7 papers) and Immunotherapy and Immune Responses (4 papers). Leontien Bosch is often cited by papers focused on Chemokine receptors and signaling (8 papers), Cervical Cancer and HPV Research (7 papers) and Immunotherapy and Immune Responses (4 papers). Leontien Bosch collaborates with scholars based in Netherlands, United States and Germany. Leontien Bosch's co-authors include Rob Leurs, Martine J. Smit, Renske D.M. Steenbergen, Peter J.F. Snijders, Chris J.L.M. Meijer, Michael Saunders, Christophe Blanchetot, Dennis Verzijl, Theo Verrips and Sven Jähnichen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Brain.

In The Last Decade

Leontien Bosch

18 papers receiving 618 citations

Peers

Leontien Bosch
Athena W. Wong United States
Jochen Beninga Germany
Yuki Fujii Japan
Gabriele Beck‐Engeser United States
Craig G. Hall United States
Shelley R. Starck United States
Mhairi Skinner Canada
Pascal Crottet Switzerland
Lorna C. Waters United Kingdom
Klaus Schwamborn France
Athena W. Wong United States
Leontien Bosch
Citations per year, relative to Leontien Bosch Leontien Bosch (= 1×) peers Athena W. Wong

Countries citing papers authored by Leontien Bosch

Since Specialization
Citations

This map shows the geographic impact of Leontien Bosch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leontien Bosch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leontien Bosch more than expected).

Fields of papers citing papers by Leontien Bosch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leontien Bosch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leontien Bosch. The network helps show where Leontien Bosch may publish in the future.

Co-authorship network of co-authors of Leontien Bosch

This figure shows the co-authorship network connecting the top 25 collaborators of Leontien Bosch. A scholar is included among the top collaborators of Leontien Bosch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leontien Bosch. Leontien Bosch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Moldován, Norbert, Sandra A.W.M. Verkuijlen, Ymke van der Pol, et al.. (2024). Comparison of cell-free and small extracellular-vesicle-associated DNA by sequencing plasma of lung cancer patients. iScience. 27(9). 110742–110742. 6 indexed citations
2.
Devalla, Harsha D., et al.. (2020). Ultrarapid Delayed Rectifier K+ Channelopathies in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Frontiers in Cell and Developmental Biology. 8. 536–536. 13 indexed citations
3.
Irvine, Elaine E., Ioanna Eleftheriadou, Leontien Bosch, et al.. (2020). Gene replacement ameliorates deficits in mouse and human models of cyclin-dependent kinase-like 5 disorder. Brain. 143(3). 811–832. 39 indexed citations
4.
Khan, Selina, Koen Oosterhuis, Kerstin Wunderlich, et al.. (2017). Development of a replication‐deficient adenoviral vector‐based vaccine candidate for the interception of HPV16‐ and HPV18‐induced infections and disease. International Journal of Cancer. 141(2). 393–404. 24 indexed citations
5.
Krijgsman, Oscar, Peter J.F. Snijders, Bauke Ylstra, et al.. (2016). Immortalization capacity of HPV types is inversely related to chromosomal instability. Oncotarget. 7(25). 37608–37621. 21 indexed citations
6.
Snellenberg, Suzanne, Saskia A.G.M. Cillessen, Wim Van Criekinge, et al.. (2014). Methylation-mediated repression of PRDM14 contributes to apoptosis evasion in HPV-positive cancers. Carcinogenesis. 35(11). 2611–2618. 33 indexed citations
7.
Snijders, Peter J.F., et al.. (2013). Differential In Vitro Immortalization Capacity of Eleven, Probable High-Risk Human Papillomavirus Types. Journal of Virology. 88(3). 1714–1724. 28 indexed citations
8.
Blanchetot, Christophe, Dennis Verzijl, Leontien Bosch, et al.. (2013). Neutralizing Nanobodies Targeting Diverse Chemokines Effectively Inhibit Chemokine Function. Journal of Biological Chemistry. 288(35). 25173–25182. 46 indexed citations
9.
Bierkens, Mariska, Oscar Krijgsman, Saskia M. Wilting, et al.. (2012). Focal aberrations indicate EYA2 and hsa‐miR‐375 as oncogene and tumor suppressor in cervical carcinogenesis. Genes Chromosomes and Cancer. 52(1). 56–68. 74 indexed citations
10.
Henken, Florianne E, Frank Rösl, Leontien Bosch, et al.. (2012). The functional role of Notch signaling in HPV-mediated transformation is dose-dependent and linked to AP-1 alterations. Cellular Oncology. 35(2). 77–84. 17 indexed citations
11.
Henken, Florianne E, Koen Oosterhuis, Peter Öhlschläger, et al.. (2012). Preclinical safety evaluation of DNA vaccines encoding modified HPV16 E6 and E7. Vaccine. 30(28). 4259–4266. 10 indexed citations
12.
Wijtmans, Maikel, Dennis Verzijl, Michael M. C. Lai, et al.. (2011). CXCR3 antagonists: Quaternary ammonium salts equipped with biphenyl- and polycycloaliphatic-anchors. Bioorganic & Medicinal Chemistry. 19(11). 3384–3393. 17 indexed citations
13.
Jähnichen, Sven, Christophe Blanchetot, David Maussang, et al.. (2010). CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells. Proceedings of the National Academy of Sciences. 107(47). 20565–20570. 198 indexed citations
14.
Wijtmans, Maikel, Dennis Verzijl, Leontien Bosch, et al.. (2009). Exploring a pocket for polycycloaliphatic groups in the CXCR3 receptor with the aid of a modular synthetic strategy. Bioorganic & Medicinal Chemistry Letters. 19(8). 2252–2257. 7 indexed citations
15.
Lim, Herman D., Paolo Conti, Miranda M.C. van der Lee, et al.. (2009). Nonpeptidergic Allosteric Antagonists Differentially Bind to the CXCR2 Chemokine Receptor. Journal of Pharmacology and Experimental Therapeutics. 329(2). 783–790. 33 indexed citations
16.
Verzijl, Dennis, Danny J. Scholten, Leontien Bosch, et al.. (2008). Noncompetitive Antagonism and Inverse Agonism as Mechanism of Action of Nonpeptidergic Antagonists at Primate and Rodent CXCR3 Chemokine Receptors. Journal of Pharmacology and Experimental Therapeutics. 325(2). 544–555. 52 indexed citations
17.
Verzijl, Dennis, Niels Elders, Leontien Bosch, et al.. (2007). Synthesis and Structure‐Activity Relationships of 3H‐Quinazolin‐4‐ones and 3H‐Pyrido[2,3‐d]pyrimidin‐4‐ones as CXCR3 receptor antagonists. Archiv der Pharmazie. 340(6). 281–291. 18 indexed citations
18.
Verzijl, Dennis, Niels Elders, Leontien Bosch, et al.. (2007). Synthesis and Structure—Activity Relationships of 3H‐Quinazolin‐4‐ones and 3H‐Pyrido[2,3‐d]pyrimidin‐4‐ones as CXCR3 Receptor Antagonists.. ChemInform. 38(41). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Athena W. Wong Breakdown of academic impact, for papers by Jochen Beninga Breakdown of academic impact, for papers by Yuki Fujii Breakdown of academic impact, for papers by Gabriele Beck‐Engeser Breakdown of academic impact, for papers by Craig G. Hall Breakdown of academic impact, for papers by Shelley R. Starck Breakdown of academic impact, for papers by Mhairi Skinner Breakdown of academic impact, for papers by Pascal Crottet Breakdown of academic impact, for papers by Lorna C. Waters Breakdown of academic impact, for papers by Klaus Schwamborn
Rankless by CCL
2026